Alzheimer's researchers say targeting brain sugar could help protect against dementia
A study recently published in the journal Nature Metabolism found that breaking down glycogen (stored glucose) in the brain could reduce the buildup of toxic proteins linked to the common dementia.
This was one of the first studies to show that glycogen may actively influence brain health and disease, according to lead author Dr. Pankaj Kapahi, a professor at the Buck Institute for Research on Aging in California.
Two Cancer Drugs Show Promise In Reversing Alzheimer's Devastating Effects
"The study began with fruit flies (Drosophila) that were genetically modified to mimic tauopathy, a condition where a protein called tau builds up in the brain, similar to what happens in Alzheimer's disease," Kapahi told Fox News Digital.
The flies used in the study were found to have brain damage and shortened lifespans, according to the researcher.
Read On The Fox News App
To ensure that the results could translate to humans, the research team also studied nerve cells made in the lab from human patient cells carrying tau mutations, as well as postmortem brain samples from people who had Alzheimer's or related conditions, according to a press release.
In both the fly and human models, the researchers found increased levels of glycogen (stored glucose) in the brain, as well as signs that glycogen breakdown was impaired, Kapahi told Fox News Digital.
This was a surprising discovery, as researchers previously thought glycogen was mainly stored in the muscles and liver.
Alzheimer's Risk Could Rise With Specific Sleep Pattern, Experts Warn
They also found that the excess glycogen contributed to disease. The tau proteins in the scientists' models interacted with glycogen, blocking it from breaking down, and the nerves lost their ability to ward off cell damage.
However, the researchers found they could decrease damage to the fruit flies and human nerves by boosting an enzyme called glycogen phosphorylase (GlyP), which breaks down glycogen.
The nerve cells used the glycogen to fight against cell damage, suggesting that the enzymes responsible for breaking down sugar could be promising targets for future therapies.
The researchers were also curious whether a restricted diet could improve the flies' brain health.
When they reduced the amount of protein in the insects' diet, the flies indeed lived longer and their brain health improved.
"We then discovered this improvement was linked to an increase in the breakdown of glycogen," Kapahi said.
This led to the study's main finding — that breaking down glycogen in neurons can protect the brain from damage caused by tau buildup.
Eating These Common Foods Could Reduce Alzheimer's Risk, Experts Say
The scientists also developed a drug using a special molecule called 8-Br-cAMP that replicated similar effects of dietary restriction, the press release noted.
The authors clarified that they are not recommending low-protein diets just yet — but said this research could pave the way for dietary or drug-based strategies to help slow Alzheimer's and related diseases.
Dr. Michael Okun, a Florida neurologist and medical advisor to the Parkinson's Foundation, was not involved in the study but commented on the significance of the findings.
"Instead of funneling sugar into energy-burning processes, the broken-down glycogen seemed to be routed into an antioxidant-producing pathway," Okun, who is also author of "The Parkinson's Plan," told Fox News Digital.
"The next step in the process may be mopping up potentially damaging free radicals roaming our brains," he said.
Okun also confirmed that dietary restrictions activated a protective brain pathway and boosted the breakdown of brain sugar.
"It ultimately reduced damage from the Alzheimer's-related tau protein," he said.
The study — which was supported by the National Institutes of Health, as well as the American Federation of Aging Research and other sources — did have some limitations, the experts acknowledged.
Click Here To Sign Up For Our Health Newsletter
The researchers did not clarify whether breaking down brain glycogen could stop human brain cells from dying, Okun noted.
"We don't yet know why glycogen builds up in disease, or whether it's a cause or a result of tau pathology — though our data suggest it may amplify disease progression," Kapahi added.
The research was also conducted only on fly and human cell models and has not yet been tested on living humans.
"We still don't know if targeting glycogen breakdown will work in human patients — and most importantly, whether it will be a safe approach," Okun said.
Alzheimer's disease, the most common form of dementia in the U.S., affects more than seven million people in the U.S., according to the Alzheimer's Association.
For more Health articles, visit www.foxnews.com/health
The neurological disorder affects memory, thinking and behavior.
There is no cure for the disease, but some medications can temporarily slow progression and improve quality of life.Original article source: Alzheimer's researchers say targeting brain sugar could help protect against dementia
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Tennessee readies for execution of man with working implanted defibrillator
NASHVILLE, Tenn. (AP) — Tennessee is gearing up for an execution on Tuesday that experts say would likely mark the first time a man has been put to death with a working defibrillator in his chest. Gov. Bill Lee declined Monday to grant a reprieve, clearing the way for Byron Black's execution after a legal battle and ongoing uncertainty about whether the implantable cardioverter-defibrillator will shock his heart when the lethal drug takes effect. The nonprofit Death Penalty Information Center said it's unaware of any other cases in which a person on death row made similar claims to Black's about defibrillators or pacemakers. Black's attorneys said they haven't found a comparable case, either. Lee said the courts have "universally determined that it is lawful to carry out the jury's sentence of execution given to Mr. Black for the heinous murders of Angela Clay and her daughters Lakeisha, age 6, and Latoya, age 9." The U.S. Supreme Court on Monday rejected Black's appeals. The execution would be Tennessee's second since May, after a pause for five years, first because of COVID-19 and then because of missteps by state corrections officials. Twenty-seven men have died by court-ordered execution so far this year in the U.S., and nine other people are scheduled to be put to death in seven states during the remainder of 2025. The number of executions this year exceeds the 25 carried out last year and in 2018. It is the highest total since 2015, when 28 people were put to death. Black's condition Black, 69, is in a wheelchair, and he has dementia, brain damage, kidney failure, congestive heart failure and other conditions, his attorneys have said. The implantable cardioverter-defibrillator he has is a small, battery-powered electronic device that is surgically implanted in the chest. It serves as a pacemaker and an emergency defibrillator. Black's attorneys say in order to be sure it's off, a doctor must place a programming device over the implant site, sending it a deactivation command, with no surgery required. In mid-July, a trial court judge agreed with Black's attorneys that officials must have his device deactivated to avert the risk that it could cause unnecessary pain and prolong the execution. But the state Supreme Court intervened July 31 to overturn that decision, saying the other judge lacked the authority to order the change. The state has disputed that the lethal injection would cause Black's defibrillator to shock him. Even if shocks were triggered, Black wouldn't feel them, the state said. Black's attorneys have countered that even if the lethal drug being used, pentobarbital, renders someone unresponsive, they aren't necessarily unaware or unable to feel pain. Kelley Henry, Black's attorney, said the execution could become a 'grotesque spectacle.' The legal case also spurred a reminder that most medical professionals consider participation in executions a violation of health care ethics. Black's case Black was convicted in the 1988 shooting deaths of his girlfriend Angela Clay, 29, and her two daughters. Prosecutors said he was in a jealous rage when he shot the three at their home. At the time, Black was on work-release while serving time for shooting Clay's estranged husband. Linette Bell, whose sister and two nieces were killed, recently told WKRN-TV: 'He didn't have mercy on them, so why should we have mercy on him?' Intellectual disability claim In recent years, Black's legal team has unsuccessfully tried to get a new hearing over whether he is intellectually disabled and ineligible for the death penalty under U.S. Supreme Court precedent. His attorneys have said that if they had delayed a prior attempt to seek his intellectual disability claim, he would have been spared under a 2021 state law. Nashville District Attorney Glenn Funk contended in 2022 that Black is intellectually disabled and deserved a hearing under that 2021 law, but the judge denied it. That is because the 2021 law denies a hearing to people on death row who have already filed a similar request and a court has ruled on it 'on the merits." In Funk's attempt, he focused on input from an expert for the state in 2004 who determined back then that Black didn't meet the criteria for what was then called "mental retardation.' But she concluded that Black met the new law's criteria for a diagnosis of intellectual disability. Black also sought a determination by the courts that he is incompetent to be executed.
Yahoo
34 minutes ago
- Yahoo
Guardians reliever Nic Enright, battling lymphoma, earns emotional first save
NEW YORK (AP) — The first career save for Nic Enright was a particularly meaningful one. Enright, who was diagnosed with Hodgkin lymphoma in late 2022 and is scheduled to complete his treatments later this year, allowed an unearned run in the 10th inning Monday night to close out the Cleveland Guardians' 7-6 win over the New York Mets. 'He was almost crying on the field just now,' Guardians manager Stephen Vogt said. 'If you read his story, it's pretty inspirational.' Cleveland selected Enright in the 20th round of the 2019 amateur draft out of Virginia Tech. He received his diagnosis Dec. 22, 2022 — 15 days after the Miami Marlins took him in the Rule 5 draft. After four rounds of immunotherapy in early 2023, Enright made nine minor league rehab appearances for the Marlins before being designated for assignment and returning to the Guardians in late May. He missed most of last season due to a right shoulder strain, but went 2-1 with a 1.06 ERA in 16 appearances with Triple-A Columbus. The right-hander has one more round of cancer treatment scheduled for November. 'I made the decision when I was diagnosed in 2022 with Hodgkin lymphoma that I wasn't going to let that define my life and dictate how I was going to go about my life,' Enright said. 'It's something where, for anyone else who is going through anything similar, (it shows) I haven't just holed up in my house and felt sorry for myself this whole time.' Enright made his major league debut May 25 and has a 2.01 ERA in 19 appearances for the Guardians, whose bullpen is in flux with All-Star closer Emmanuel Clase on paid leave as part of a sports gambling investigation. Hunter Gaddis and Cade Smith pitched the eighth and ninth innings Monday before Enright entered with a two-run lead. He gave up a two-out RBI single to Brett Baty before retiring Luis Torrens on a fly out to the warning track in right. 'I definitely held my breath as I saw Nolan (Jones) kind of keep running,' Enright said. 'But I had faith. As he kind of got closer to the wall, I realized it was losing steam.' Enright was showered with beer by teammates in the locker room. 'I was so happy, oh, I was going nuts in here,' Guardians starting pitcher Slade Cecconi said with a smile. 'I was going absolutely berserk. He came in running up the stairs, smile on his face.' Enright thanked his wife, his parents and the rest of his family for their support throughout an interview at his locker. He got the ball from the final out and plans to set aside his uniform and hat as well as a lineup card. 'Really, really cool,' Enright said. 'These last couple of years, especially, I've gone through a lot of adversity and just everything that's gone on. And so for me, it's being able to reflect on those in these moments. I think that helps being able to slow the game down. Because it hasn't exactly been a red-carpet rollout for my career trajectory.' ___ AP MLB:

Associated Press
34 minutes ago
- Associated Press
Guardians reliever Nic Enright, battling lymphoma, earns emotional first save
NEW YORK (AP) — The first career save for Nic Enright was a particularly meaningful one. Enright, who was diagnosed with Hodgkin lymphoma in late 2022 and is scheduled to complete his treatments later this year, allowed an unearned run in the 10th inning Monday night to close out the Cleveland Guardians' 7-6 win over the New York Mets. 'He was almost crying on the field just now,' Guardians manager Stephen Vogt said. 'If you read his story, it's pretty inspirational.' Cleveland selected Enright in the 20th round of the 2019 amateur draft out of Virginia Tech. He received his diagnosis Dec. 22, 2022 — 15 days after the Miami Marlins took him in the Rule 5 draft. After four rounds of immunotherapy in early 2023, Enright made nine minor league rehab appearances for the Marlins before being designated for assignment and returning to the Guardians in late May. He missed most of last season due to a right shoulder strain, but went 2-1 with a 1.06 ERA in 16 appearances with Triple-A Columbus. The right-hander has one more round of cancer treatment scheduled for November. 'I made the decision when I was diagnosed in 2022 with Hodgkin lymphoma that I wasn't going to let that define my life and dictate how I was going to go about my life,' Enright said. 'It's something where, for anyone else who is going through anything similar, (it shows) I haven't just holed up in my house and felt sorry for myself this whole time.' Enright made his major league debut May 25 and has a 2.01 ERA in 19 appearances for the Guardians, whose bullpen is in flux with All-Star closer Emmanuel Clase on paid leave as part of a sports gambling investigation. Hunter Gaddis and Cade Smith pitched the eighth and ninth innings Monday before Enright entered with a two-run lead. He gave up a two-out RBI single to Brett Baty before retiring Luis Torrens on a fly out to the warning track in right. 'I definitely held my breath as I saw Nolan (Jones) kind of keep running,' Enright said. 'But I had faith. As he kind of got closer to the wall, I realized it was losing steam.' Enright was showered with beer by teammates in the locker room. 'I was so happy, oh, I was going nuts in here,' Guardians starting pitcher Slade Cecconi said with a smile. 'I was going absolutely berserk. He came in running up the stairs, smile on his face.' Enright thanked his wife, his parents and the rest of his family for their support throughout an interview at his locker. He got the ball from the final out and plans to set aside his uniform and hat as well as a lineup card. 'Really, really cool,' Enright said. 'These last couple of years, especially, I've gone through a lot of adversity and just everything that's gone on. And so for me, it's being able to reflect on those in these moments. I think that helps being able to slow the game down. Because it hasn't exactly been a red-carpet rollout for my career trajectory.' ___ AP MLB: